Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
A catheter-based procedure to close holes in patients’ hearts proved no better at preventing recurrent strokes than medication alone, according to a study published today in the New England Journal of Medicine.
Boston Scientific (NYSE:BSX) can’t dodge a false claims lawsuit filed against its Guidant pacemaker division after a federal judge shot down its move to have the case dismissed. James Allen sued Guidant and Boston Scientific in July 2008 under the False Claims Act, alleging that the company knew of problems with its Ventak Prizm device but failed to disclose them.
Outgoing Johnson & Johnson (NYSE:JNJ) CEO William Weldon will take home $143.5 million in retirement benefits when he walks in April. The veteran J&J employee racked up more than $95 million in deferred compensation and $48.4 million in pension benefits over more than 40 years with the health care titan, according to an SEC filing.